Norway· NO-ID_CE8746B5-DDF2-4802-880A-3E7B60CA7623
Bevespi Aerosphere
A formoterol und glycopyrronium bromid product containing glycopyrronium bromide + formoterol fumarate dihydrate, registered in Norway by AstraZeneca AB (2). The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Formoterol und glycopyrronium bromid is registered in 9 of 19 countries.
Countries holding a registration under ATC R03AL07 (formoterol und glycopyrronium bromid), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Formoterol und glycopyrronium bromid · ATC R03AL07
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
FEST (Norway)- Active substance
- Glycopyrronium Bromide + Formoterol Fumarate Dihydrate
- Manufacturer
- AstraZeneca AB (2)
- Country
- Norway (NO)
- ATC code
- R03AL07
- ATC class
- Formoterol und Glycopyrronium bromid
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
2 priced- no_varenummer527575120NOK 597.6
- no_merkevare_idID_CE8746B5-DDF2-4802-880A-3E7B60CA7623
- no_varenummer0852203 x 120NOK 1720.4
- gtin5000456033046
- gtin5000456057585
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol und glycopyrronium bromid in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBEVESPI AEROSPHEREAstraZeneca AB, Södertälje
- FinlandBevespi AerosphereAstraZeneca AB
- United KingdomBevespi Aerosphere 7.2micrograms/dose / 5micrograms/dose pressurised inhalerAstraZeneca UK Ltd
- SwedenBevespi Aerosphere 7,2 mikrogram/5 mikrogram Inhalationsspray, suspensionAstraZeneca AB
- United StatesBEVESPI AEROSPHEREAstraZeneca Pharmaceuticals LP
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Bevespi Aerosphere
- Liechtenstein · Bevespi Aerosphere
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9de14531-eb50-449f-8bf8-d291bf973324 GET /v1/drugs/9de14531-eb50-449f-8bf8-d291bf973324?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Inhalasjonsaerosol, suspensjon",
"source": "fest",
"status": "A",
"atc_name": "Formoterol og glykopyrronbromid",
"merkevare_id": "ID_CE8746B5-DDF2-4802-880A-3E7B60CA7623",
"name_form_strength": "Bevespi Aerosphere inh aerosol, susp 7,2 mikrog/5 mikrog",
"prescription_group": "C"
}See everything about formoterol und glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.